Trust these guys
Third order from MyPeptides. Purity and appearance are consistent across batches. The paperwork is genuinely useful - mass, structure and CAS all included.

5 mg · ≥99% purity
Dual GIP/GLP-1 receptor agonist research peptide.
£99.00 per vial · Tax calculated at checkout · Free tracked UK & EU shipping over £50

Every batch is independently HPLC assayed. Certificate of Analysis available on request.
Every UK order includes — free
Full refund
if a batch is off-spec
Free reship
if lost or damaged in transit
Same-day dispatch
Mon–Fri, order before 12:00 UK
Research use only
for laboratory work
Analytical data
Identity data cross-checked against PubChem; purity taken from the batch certificate of analysis.
About this compound
Dual GIP / GLP-1 analogue
Half-life
≈ 5 days
First disclosed
2018
Tirzepatide is a 39-amino-acid synthetic peptide that activates both the GIP and GLP-1 receptors. Originally disclosed by Eli Lilly in 2018, it is among the most-studied incretin compounds in laboratory metabolic-pathway research, with peer-reviewed work spanning receptor binding and incretin-axis signalling models.
Co-activation of the GIP and GLP-1 receptors is studied in vitro for its combined effect on incretin-receptor signalling pathways.
Research areas
Research literature
Browse this research area
Tirzepatide is a dual GIP and GLP-1 receptor agonist peptide, supplied by MyPeptides for laboratory research use only.
Tirzepatide is a 39-amino-acid synthetic peptide that activates both the GIP and GLP-1 receptors (C₂₂₅H₃₄₈N₄₈O₆₈, CAS 2023788-19-2). First disclosed in 2018, it is among the most-studied compounds in laboratory incretin-pathway research.
It is supplied here as a 5 mg lyophilised vial and as a 40 mg pre-filled research pen, so protocols can use whichever format suits the workflow.
Compare it with semaglutide (GLP-1 only), mazdutide (GLP-1 + glucagon) and retatrutide (GIP + GLP-1 + glucagon) in our GLP-1 & incretin range. Store at −20 °C, protected from light. Laboratory research use only.
Straight answers on purity, handling, dispatch and research use.
Tirzepatide is a dual GIP and GLP-1 receptor agonist peptide, supplied by MyPeptides as a lyophilised research vial for laboratory research use only.
In cited literature, Tirzepatide is studied in dual-incretin, glycaemic and metabolic research. It is not a medicine and is not intended for human or veterinary use.
Every batch is third-party HPLC assayed at ≥99% purity. A signed certificate of analysis is available on request after checkout.
Ships lyophilised in a sealed borosilicate vial. Store at −20 °C; reconstitute with bacteriostatic or sterile water immediately before in vitro use.
Yes — tracked Royal Mail and DPD dispatch across the UK and EU, with free shipping on orders over £50. Weekday orders placed before 12:00 UK time ship the same day.
Verified feedback from qualified researchers across the UK & EU.
Third order from MyPeptides. Purity and appearance are consistent across batches. The paperwork is genuinely useful - mass, structure and CAS all included.
Really impressed with the packaging quality. Everything double-boxed, insulated and clearly labelled. Same day dispatch worked as promised.
Documentation is what sold me. Independent CoA per batch, clean HPLC traces. Reconstitution behaved exactly as expected. Solid supplier for research use.
Shipping to mainland EU took 3 working days, tracked the whole way. Vials arrived intact, labels crisp, seals unbroken. Reordering next month.
The little details matter - proper cold-chain, tamper-evident seals, and a CoA that actually reads like a lab report and not a marketing sheet.
Ordered a bundle to save on shipping - all vials arrived in one insulated pack, labels identical batch, CoA covers the lot. Great value.
More peptides from the mypeptides research catalog.